U.S. Department of Health & Human Services

NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Recently Added Within 6 Months Remove constraint Recently Added: Within 6 Months Copyright Public domain Remove constraint Copyright: Public domain Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later
Number of results to display per page

Search Results

3. Data inadequacies undermine CMS's oversight of the inconsistency resolution process for the federal marketplace

nlm:nlmuid-101737746-pdf

4. CMS validated hospital inpatient quality reporting program data, but should use additional tools to identify gaming

nlm:nlmuid-101737750-pdf

6. CDC generally met its inspection goals for the federal select agent program: however, opportunities exist to strengthen oversight

nlm:nlmuid-101737763-pdf

8. Round 2 competitive bidding for CPAP/RAD: disrupted access unlikely for devices, inconclusive for supplies

nlm:nlmuid-101737773-pdf

10. OHRP generally conducted its compliance activities independently, but changes would strengthen its independence

nlm:nlmuid-101737781-pdf

11. HHS's Office of Refugee Resettlement improved coordination and outreach to promote the safety and well-being of unaccompanied alien children

nlm:nlmuid-101737785-pdf

12. Medicare program shared savings accountable care organizations have shown potential for reducing spending and improving quality

nlm:nlmuid-101737819-pdf

24. Enhancements needed in the tracking and collection of Medicare overpayments identified by ZPICS and PSCS

nlm:nlmuid-101737930-pdf

28. Medicare payments for clinical diagnostic laboratory tests in 2016: year 3 of baseline data

nlm:nlmuid-101737978-pdf

29. Excluding noncovered versions when setting payment for two Part B drugs would have resulted in lower drug costs for Medicare and its beneficiaries

nlm:nlmuid-101737981-pdf

31. Followup review: CMS's management of the quality payment program

nlm:nlmuid-101737984-pdf

32. Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates

nlm:nlmuid-101737986-pdf

36. Round two competitive bidding for oxygen: continued access for vast majority of beneficiaries

nlm:nlmuid-101737992-pdf

37. Round two competitive bidding for enteral nutrition: continued access for vast majority of beneficiaries

nlm:nlmuid-101738020-pdf

38. HRSA helped health centers with elevated risks and can continue to take additional steps

nlm:nlmuid-101738030-pdf

44. CMS did not detect some inappropriate claims for durable medical equipment in nursing facilities

nlm:nlmuid-101738059-pdf

45. Opioids in Ohio Medicaid: review of extreme use and prescribing

nlm:nlmuid-101738060-pdf

49. Questionable billing for compounded topical drugs in Medicare Part D

nlm:nlmuid-101738131-pdf

50. FDA should further integrate its review of cybersecurity into the premarket review process for medical devices

nlm:nlmuid-101738136-pdf